Log in or Sign up for Free to view tailored content for your specialty!
Skin Disorders News
Breast-feeding does not affect allergy sensitization in children
The time a mother spends breast-feeding her child has no impact on the development of allergy sensitization in children at high risk for developing allergies, according to recent study results.
Children with allergies at greater risk for primary immune thrombocytopenia
Children with common allergic diseases such as atopic dermatitis and allergic rhinitis showed a greater risk for developing primary immune thrombocytopenia, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
Long-term Cosentyx effectively treats patients with psoriasis
SAN FRANCISCO — Seventy percent of patients with psoriasis had clear or almost clear skin after 2 years of therapy with Cosentyx 300 mg, according to a press release issued at the American Academy of Dermatology Annual Meeting.
Mast cells produce IL-22, may cause psoriasis, AD
Human skin mast cells are previously unrecognized interleukin-22 producers and express interleukin-17 that may contribute to inflammatory skin disorders, according to study results.
Novel boron-based ointment safe in treating atopic dermatitis in children
AN2728 ointment 2%, a novel boron-based small-molecule ointment, might be effective for the treatment of patients ages 2 years and older with mild-to-moderate atopic dermatitis, according to research presented during a late-breaking research session.
Claims algorithm identifies patients with chronic urticaria
An ICD-9-CM–based algorithm was validated by accurately identifying patients with chronic idiopathic urticaria and chronic spontaneous urticaria, according to study results.
Trial drug shows clinical improvements in plaque psoriasis
An experimental drug was well tolerated and associated with improvements in patients with moderate to severe chronic plaque psoriasis, according to study results.
Increases in medical, recreational marijuana use raise allergy concerns
As marijuana becomes increasingly common and legally accessible in some states, clinicians have an increased concern regarding the potential allergens associated with the use and handling of Cannabis sativa.
Tradipitant effectively treats AD despite placebo effect
Tradipitant was considered safe and effective as monotherapy for chronic pruritus in patients with atopic dermatitis despite a high placebo effect, according to a drugmaker’s press release.
FDA advisory committee agrees on need for pediatric studies on atopic dermatitis
An FDA advisory committee agreed there is an unmet medical need for systemic products, drugs, and biologics, along with additional clinical studies, for the treatment of children with atopic dermatitis who do not respond adequately to topical therapy.